Premature Ventricular Contraction-Induced Cardiomyopathy: Contemporary Evidence from Risk Stratification, Pathophysiology, and Management
Issued Date
2024-05-01
Resource Type
eISSN
20770383
Scopus ID
2-s2.0-85192757835
Journal Title
Journal of Clinical Medicine
Volume
13
Issue
9
Rights Holder(s)
SCOPUS
Bibliographic Citation
Journal of Clinical Medicine Vol.13 No.9 (2024)
Suggested Citation
Attachaipanich T., Thiravetyan B., Tribuddharat N., Jaroonpipatkul S., Navaravong L. Premature Ventricular Contraction-Induced Cardiomyopathy: Contemporary Evidence from Risk Stratification, Pathophysiology, and Management. Journal of Clinical Medicine Vol.13 No.9 (2024). doi:10.3390/jcm13092635 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/98377
Title
Premature Ventricular Contraction-Induced Cardiomyopathy: Contemporary Evidence from Risk Stratification, Pathophysiology, and Management
Author's Affiliation
Corresponding Author(s)
Other Contributor(s)
Abstract
Premature ventricular complexes (PVCs) are commonly encountered problems in clinical settings. The range of symptoms can be from asymptomatic to palpitations, fatigue, or heart failure symptoms. A higher burden of PVCs is a risk factor for development of PVC-induced cardiomyopathy (PIC). Rhythm evaluation by 12-lead ECG and an ambulatory monitoring device are essential. Currently, several imaging modalities, such as echocardiography and cardiac magnetic resonance imaging, are utilized to evaluate the underlying structure that may be related to PIC. Beta blockers and antiarrhythmic drugs are typically part of the initial management strategy. If these fail, catheter ablation of PVCs is typically the next step. The purpose of this article is to summarize the current evidence/knowledge about PIC.